蜈蚣
发表于 2025-3-26 22:20:01
Cooperation between the Surgical Oncologist and the Pathologistthe last decade the multidisciplinary treatment of oncologic diseases has become increasingly integrated and decreasingly sequential. The aim of cooperation is to provide quality treatment and produce new knowledge through both basic and clinical research and medical education.
使激动
发表于 2025-3-27 01:25:35
Molecular Biology and Genetics of Cancerain-of-function or loss-of-function changes affect a number of genes that control cellular processes such as cell cycle, apoptosis and differentiation and that consequently behave as oncogenes or tumor suppressors, respectively. It is also well established that several genetic hits are required to t
LATHE
发表于 2025-3-27 08:22:23
The Medical Oncologist’s Point of Viewry and/or radiotherapy have been traditionally the primary chosen treatments in solid tumors. However, neither modality can be considered curative once disease is beyond the local region, and clinical evidence has already shown that surgical removal or radiotherapeutic ablation of “localized” masses
语言学
发表于 2025-3-27 11:48:54
http://reply.papertrans.cn/89/8825/882435/882435_34.png
Painstaking
发表于 2025-3-27 16:07:49
http://reply.papertrans.cn/89/8825/882435/882435_35.png
prolate
发表于 2025-3-27 20:25:48
http://reply.papertrans.cn/89/8825/882435/882435_36.png
LEER
发表于 2025-3-27 23:47:52
Surgery in Multimodal Treatment of Cancer: Peritoneal Carcinomatosiseeks or months. Since the 1980s, following the intuition of an American surgeon, Paul Sugarbaker, combined treatment modalities of PC have developed considerably. Since the first pioneering approaches on the treatment of “pseudomyxoma peritonei”
senile-dementia
发表于 2025-3-28 03:40:59
http://reply.papertrans.cn/89/8825/882435/882435_38.png
placebo
发表于 2025-3-28 07:07:14
http://reply.papertrans.cn/89/8825/882435/882435_39.png
发微光
发表于 2025-3-28 14:21:09
Molecular Biology and Genetics of Canceroordinated way, to compose the complex network of the cancer phenotypic traits . Elucidating how such gene function diversity is generated during the tumorigenic events is an unanswered question. Although tremendous advances in knowledge have occurred in recent years, there is still no clear understanding in this field.